Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Brigade Capital Can’t Stop Buying Shares Of Bon-Ton Stores Inc. (BONT)

Page 1 of 2

Donald Morgan’s Brigade Capital Management revealed a 14.7% ownership stake in Bon-Ton Stores Inc. (NASDAQ:BONT) consisting of 2.78 million shares, in a recent 13G filing with the SEC. The stake just the latest increase to the fund’s position in the company, having been increased by 1.78 million shares from the 1.00 million shares that were disclosed in another 13G filing on May 22 and by nearly 2.13 million shares since the fund’s most recently filed 13F for the reporting period of March 31.

The Bon-Ton Stores, Inc. (NASDAQ:BONT)

Brigade Capital Management is New York-based hedge fund specializing in credit investment strategies, co-founded by Donald Ellis Morgan in 2006. The asset management firm primarily employs a multi-strategy, multi-asset class investment approach with a focus on companies with leveraged balance sheets. Brigade Capital’s investment strategies include: long/short credit, opportunistic credit, distressed debt, traditional high yield, long/short equity, and structured credit, to name just a few. Don Morgan had acted as a Senior Managing Director and Co-Head of Fixed Income at MacKay Shields LLC, managing its High Yield Division for six years prior to launching Brigade. He managed to grow the firm’s high yield assets from $7 billion to $16 billion and raise a $750 million long/short fund. Moreover, Don Morgan was a High Yield Analyst at Fidelity Management and Research Company even before joining MacKay Shields; thus, his expertise in high yield and distressed debt investing is unquestionable. Brigade Capital Management’s public equity portfolio is worth $1.52 billion as of March 31, 2015.

Don Morgan
Don Morgan
Brigade Capital

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 139% over the ensuing 34 months, outperforming the S&P 500 Index by 81 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Bon-Ton Stores Inc. (NASDAQ:BONT) is one of the largest regional department store operators in the United States, providing a large portfolio of brand-name fashion apparel and accessories. Bon-Ton’s portfolio of merchandise offerings also comprises cosmetics, home furnishings, and other goods. The company operates 270 stores, including nine furniture galleries and four clearance centers, under the Bon-Ton, Bergner’s, Boston Store, Carson’s, Elder-Beerman, Herberger’s, and Younkers nameplates. The shares of Bon-Ton have decreased by 21% since the beginning of the current year, however the stock has been riding a strong uptrend more recently, achieving a gain of over 32% so far in July.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!